Prelude Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Prelude Capital Management's GHDX Position: Q4 2019 in Review

Prelude Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,694 shares — an estimated $251K sold.

Prelude Capital Management first reported a position in GHDX in Q1 2014 and held it in 15 quarters. The position peaked at $251K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

• Prelude Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
• Prelude Capital Management sold 3,694 Genomic Health, Inc. shares in Q4 2019, an estimated $251K.
• Prelude Capital Management first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 15 quarters.
• Prelude Capital Management's Genomic Health, Inc. position peaked at $251K in Q3 2019.
• 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.